Affinia Therapeutics
49 employees
Biotech/Pharma
Series C · $210.0M
Open positions (1)
Company details
Team Size49
IndustryBiotech/Pharma
Funding
Total raised
$210.0M
Last stage
Series C
Investors
F-Prime Capital
Total raised
$210.0M
Last stage
Series C
Investors
Luk Vandenberghe
Grousbeck Family Chair in Gene Therapy and director of the Grousbeck Gene Therapy Center at Massachusetts Eye and Ear; associate professor of ophthalmology at Harvard Medical School; co-inventor of AAV9.
Botond Roska
Founding director of the Institute of Molecular and Clinical Ophthalmology Basel, and professor in the Faculty of Science and Medicine at the University of Basel. Leader in gene therapy, regulatory elements, and neuronal circuits.
Aaron Tward
Associate professor at the University of California, San Francisco (UCSF); surgeon-scientist and pioneer in high-throughput sequencing technologies applied to biomedicine.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.